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Introduction: Indications for renal replacement therapy (RRT) have not been generally standardized and vary
among intensive care units (ICUs). We aimed to assess the proportion, indications, and modality of RRT, as well as
the association between the proportion of RRT use and 90-day mortality in patients with septic shock in Finnish
adult ICUs.
Methods: We identified patients with septic shock from the prospective observational multicenter FINNAKI study
conducted between 1 September 2011 and 1 February 2012. We divided the ICUs into high-RRT and low-RRT ICUs
according to the median of the proportion of RRT-treated patients with septic shock. Differences in indications, and
modality of RRT between ICU groups were assessed. Finally, we performed an adjusted logistic regression analysis
to evaluate the possible association of the ICU group (high vs. low-RRT) with 90-day mortality.
Results: Of the 726 patients with septic shock, 131 (18.0%, 95% CI 15.2 to 20.9%) were treated with RRT. The
proportion of RRT-treated patients varied from 3% up to 36% (median 19%) among ICUs. High-RRT ICUs included
nine ICUs (354 patients) and low-RRT ICUs eight ICUs (372 patients). In the high-RRT ICUs patients with septic shock
were older (P = 0.04), had more cardiovascular (P <0.001) and renal failures (P = 0.003) on the first day in the ICU,
were more often mechanically ventilated, and received higher maximum doses of norepinephrine (0.25 μg/kg/min
vs. 0.18 μg/kg/min, P <0.001) than in the low-RRT ICUs. No significant differences in indications for or modality of
RRT existed between the ICU groups. The crude 90-day mortality rate for patients with septic shock was 36.2%
(95% CI 31.1 to 41.3%) in the high-RRT ICUs compared to 33.9% (95% CI 29.0 to 38.8%) in the low-RRT ICUs, P = 0.5.
In an adjusted logistic regression analysis the ICU group (high-RRT or low-RRT ICUs) was not associated with 90-day
mortality.
Conclusions: Patients with septic shock in ICUs with a high proportion of RRT had more severe organ dysfunctions
and received more organ-supportive treatments. Importantly, the ICU group (high-RRT or low-RRT group) was not
associated with 90-day mortality.* Correspondence: meri.poukkanen@lshp.fi
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Sepsis is a common cause of acute kidney injury (AKI)
[1,2] and up to 64% of patients with septic shock have a
concomitant AKI [3-5]. According to previous studies 9
to 20% of the patients with septic shock receive renal re-
placement therapy (RRT) [3,6,7]. Septic AKI has a poor
outcome [3,6-8] and it independently increases the risk
of death [1].
The treatment of AKI is primarily supportive inclu-
ding RRT. Excluding few absolute indications for RRT,
such as hyperkalemia, severe metabolic acidosis, overt
uremia, and specific drug intoxications, the decision
for the initiation of RRT is usually based on local cli-
nical practice and the individual opinion of the attend-
ing physician. The Beginning and Ending Supportive
Therapy for the Kidney (B.E.S.T) study reported marked
practice variation for RRT globally [9]. Despite multiple
studies, the optimal timing, modality, and anticoagula-
tion of RRT are still largely unclear. According to recent
studies even the overall beneficial effect of RRT is un-
certain [10,11]. In patients with sepsis-associated AKI in
a surgical intensive care unit (ICU) RRT has been found
to be associated with increased mortality [10]. Likewise
a recent study reported worse prognoses in patients
with AKI receiving RRT compared to conservative treat-
ment [11].
Accordingly, we aimed to assess the variation of RRT
in patients with septic shock in this substudy of the
multicenter prospective observational FINNAKI study
[12]. Additionally, we evaluated the possible associa-
tion of the relative proportion of RRT treatment (high-
vs. low-RRT ICUs) and 90-day mortality in septic shock.Materials and methods
We retrieved patients with septic shock from the pro-
spective, observational FINNAKI study conducted in 17
Finnish adults ICUs between 1 September 2011 and
1 February 2012 [12]. All emergency admissions and
elective postoperative admissions with an expected ICU
stay of more than 24 hours were included in the FINNAKI
study. Intermediate care patients, patients on chronic
dialysis, elective patients with an expected stay in the
ICU of less than 24 hours, readmitted patients who
had received RRT during the previous ICU admission,
transferred patients who had already participated in
the study for five days, patients with inadequate lan-
guage skills or not permanently living in Finland, pa-
tients under 18 years of age, and organ donors were
excluded from the study. The Ethics Committee of the
Helsinki University Hospital approved the study proto-
col and the use of deferred consent (DNRO 18/13/03/
02/1010). A written consent was obtained from patients
or proxy.Definitions
We defined septic shock according to the American
College of Chest Physicians/Society of Critical Care
Medicine (ACCP/SCCM) criteria [13]. We used the Kid-
ney Disease: Improving Global Outcome (KDIGO) criteria
[14] to define and stage AKI by using both serum creatin-
ine (SCr) and urine output criteria. KDIGO classification
defines AKI as an increase in SCr by ≥26.5 μmol/l within
48 hours, or an increase in SCr to ≥1.5 times baseline, or
urine volume less than 0.5 ml/kg/h for 6 hours. RRT-
related complications were defined as follows: complica-
tion in catheter insertion (arterial insertion, pneumo- or
hemothorax, severe hematoma), severe bleeding, hypoten-
sion during RRT (need for fluid resuscitation, increasing
the dose of vasoactive treatment or discontinuing the
treatment), severe electrolyte disturbance (hypophospha-
temia, hypocalcemia, hypokalemia), and catheter-related
infection. We defined organ failure as Sequential Organ
Failure Assessment score (SOFA) ≥3 [15,16]. The prob-
ability of death was calculated according to the original
Simplified Acute Physiology Score (SAPS) equation [17].
The data on survival at 90 days were obtained from the
Finnish Population Register Center.
Data source
For the current study we identified all patients with sep-
tic shock from the FINNAKI study [12]. The FINNAKI
data were prospectively collected to the database of
the Finnish Intensive Care Consortium maintained by
Tieto Ltd., Helsinki, Finland. The database included
demographic data, main physiologic and laboratory
variables, SAPS II [17], SOFA scores [16], data on organ-
supportive treatments, and outcomes. We used an add-
itional internet-based case report form (CRF) to record
data on chronic health status, medications, presence of se-
vere sepsis or septic shock, and RRT. We collected CRF
data daily for the first five days in the ICU and thereafter
data on RRT twice a week of RRT-treated patients. Treat-
ment restrictions were recorded as withholding or discon-
tinuation of RRT, withdrawal of intensive care treatment,
or decision not to resuscitate. The attending ICU physi-
cians selected the indication for RRT from the following
list: oliguria/anuria, azotemia/high creatinine, rhabdomyo-
lysis, metabolic acidosis, hyperkalemia, fluid overload, im-
munomodulation, drug intoxication, and others. Multiple
indications could be registered.
Altogether seventeen ICUs participated in the FINNAKI
study (six university ICUs and eleven nonacademic, cen-
tral hospital ICUs). Each participating ICU had the cap-
acity to provide RRT. To assess the association of relative
proportion of RRT use with 90-day mortality in patients
with septic shock, we calculated the proportion of patients
with septic shock treated with RRT in an individual ICU.
The median of proportion of RRT was used as a cutoff
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The low-RRT group included eight ICUs (three university
ICUs and five central hospital ICUs, altogether 372 pa-
tients) and the high-RRT group comprised nine ICUs
(three university ICUs and six central hospital ICUs,
altogether 354 patients).
Statistics
We report continuous data as medians with interquar-
tile range (IQR) and categorical data as absolute values
and percentage. We report the main outcomes with 95%
confidence interval (95% CI). We compared categorical
data with chi-square or Fisher’s exact test and continu-
ous data with Mann–Whitney U test. We calculated the
standardized mortality ratio (SMR) by dividing the num-
ber of observed deaths with the predicted number of
deaths according the original SAPS II equation [17]. To
decrease the influence of treatment selection bias for ini-
tiation of RRT, we generated a propensity score by logis-
tic regression [18,19]. In the propensity score we entered
confounders related to the probability of receiving RRT:
creatinine value on the first day in the ICU (D1), urine
output on the D1, age categorized by Acute Physiology
and Chronic Health Evaluation (APACHE) age groups
[20], any comorbidity, SAPS II score without age and
renal components, and SOFA score without renal points
on the D1. We evaluated the association of the risk fac-
tors with 90-day mortality by univariable analysis. We
then entered the factors with P <0.2 into the multivari-
able logistic regression model to analyze any possible as-
sociation with 90-day mortality. We first performed theHigh-RRT ICUs
-  9 ICUs (354 patients)
256 patients 
without RRT
-  90-day mortality







-  90-day mortality
   49.0% (48)
Figure 1 Flow chart of patients with septic shock with or without ren
care units (ICUs).regression model for 90-day mortality without a propen-
sity score and then with the propensity score excluding
variables that interacted with the propensity score. We
present the results of the logistic regression model with
odds ratios (OR) with 95% CI. Goodness-of-fit was eval-
uated using the Hosmer-Lemeshow test. We report two-
tailed P values and considered a P value less than 0.05
to be statistically significant. We performed all analyses
using the IBM SPSS statistics software version 20.0 (IBM
Corp., Armonk, NY, USA).
Results
Altogether 726 patients fulfilled the criteria of septic
shock. Of these 726 patients with septic shock, 131
(18.0%, 95% CI 15.2 to 20.9%) were treated with RRT.
The main indications for RRT were oliguria (85%), aci-
dosis (73.3%), high creatinine (60.3%), and fluid overload
(42.0%). The data of the indication, modality, and anticoa-
gulation of RRT are presented in the additional file (Table
S1 in Additional file 1).
Low-RRT and high-RRT ICUs
The number of patients with septic shock in each ICU
varied from 22 to 79 patients (median [IQR] 44.5 pa-
tients, [25.8 to 70.3]) in the low-RRT ICUs and from 8
to 99 patients (median [IQR] 36.0, [15.5 to 60.5]) in the
high-RRT ICUs. Figure 1 presents the study flow chart
with the number of patients with or without RRT in low-
and high-RRT ICUs. The proportion of RRT-treated pa-
tients with septic shock ranged from 3% (2/76) to 16%




-  8 ICUs (372 patients)
33 RRT-treated
patients
-  90-day mortality
   57.6% (19)
339 patients 
without RRT
-  90-day mortality
   31.6% (107)
al replacement therapy (RRT) in low-RRT and high-RRT intensive
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proportions of patients with septic shock and AKI (that
is, patients at risk for RRT) are presented in Figure 2.
Of the participating six university ICUs, three belonged
to the high-RRT ICUs (proportion of RRT 25%, 25%,
and 35%) and three to the low-RRT ICUs (proportion
of RRT 3%, 6%, and 11%). The median number of ICU
beds in the low-RRT ICUs was 16.0 (8.0 to 19.0) and
in the high-RRT ICUs 10.0 (7.0 to 16.0). The median
[IQR] for total RRT-days in septic shock indexed to ICU
beds was 2.1 [1.5 to 2.9] in the low-RRT ICUs compared
to 4.5 [1.3 to 9.9] in the high-RRT ICUs, P = 0.2.
Patients in the high-RRT and low-RRT ICUs
The patients with septic shock in the high-RRT ICUs
were older (P = 0.04), had emergency (P <0.001), and op-
erative (P = 0.01) admission more often, and had more
abdominal infections (P = 0.007) than in the low-RRT
ICUs (Table 1). The proportion of patients with AKI and
the severity of AKI according to the KDIGO classifica-
tion in the high- and low-RRT ICUs are presented in
Table 2. The proportions of cardiovascular (P <0.001)
and renal (P = 0.003) organ failures (SOFA 3 or 4) within
the first day in the ICU were greater among patients
treated in the high-RRT ICUs than in the low-RRT ICUs
(Table 2). In the high-RRT ICUs patients were mecha-
nically ventilated more often (P <0.001), received sep-
sis corticosteroid more often (P <0.001) and received a
higher maximum dose of norepinephrine (P <0.001) dur-
ing the first five days in the ICU (Table 2). The lowest
base excess (BE) for 24 hours prior to ICU admission or
within the first 24 hours in the ICU was −5.4 [−10.6 to
(−2.5)] in the high-RRT ICUs compared to −4.1 [8.7 to
(−1.1)] in the low-RRT ICUs, P <0.001. The highest lac-
tate value during the first five days in the ICU was higherFigure 2 Proportions and absolute numbers of renal replacement the
injury (AKI) in each intensive care unit (ICU).in the high-RRT ICUs [2.5 mmol/l, (1.6 to 4.4 mmol/l)]
than in the low-RRT ICUs [2.2 mmol/l (1.4 to 4.0 mmol/l)],
P = 0.02.
RRT treatment
Patients treated with RRT did not differ in age, gender,
or severity of illness between high- and low-RRT ICUs
(Additional file 2). Apart from high creatinine, indica-
tions for and modalities of RRT were corresponding in
both ICU groups. RRT was initiated in both ICU groups
within the first 24 hours in the ICU. Citrate was used
more often in the low-RRT ICUs than in the high-RRT
ICUs (P = 0.004), otherwise the use of anticoagulation
for RRT was similar in ICU groups. Table 3 presents the
data of RRT in high- and low-RRT ICUs. The laboratory
values preceding RRT did not differ between high- and
low-RRT groups (Additional file 3). Patients without
RRT were older in the high-RRT ICUs, and they re-
ceived more often furosemide than in the low-RRT ICUs
(Additional file 4).
Treatment restrictions
Of the 726 patients with septic shock, RRT was restric-
ted in 71 patients (9.8%) comprising 44 (6.1%) withhol-
dings and 27 (3.7%) withdrawals of RRT. Patients with
restricted RRT were older (69.4 vs. 65.0 years, P = 0.009),
had higher nonrenal SOFA score on the first day in ICU
(11.0 vs. 9.0, P = 0.004) and higher SAPS II score on ad-
mission (59.5 vs. 44.0, P <0.001) than patients without
RRT restrictions. Any treatment restriction (withdrawal
of intensive care, withholding or withdrawal of RRT, and
decision not to resuscitate) was made as often in the
low-RRT group as in the high-RRT group (Table 1). There
were no differences in age, number of comorbidities, non-
renal SOFA score on the first day in ICU, or SAPS II scorerapy (RRT) delivered for patients and patients with acute kidney
Table 1 Demographic of patients with septic shock divided by low- or high-renal replacement therapy (RRT) intensive
care units (ICUs)
Patients in low-RRT ICUs (n = 372) Patients in high-RRT ICUs (n = 354) P value
Age (years) 64.0 [54.0–74.0] 67.0 [56.0–76.0] 0.04
Gender (male) 243 (65.3) 221 (62.4) 0.4
Any comorbidity1 237 (64.9) 250 (71.2) 0.07
Community-acquired infection 103 (29.5) 106 (32.8) 0.4
Source of infection
Pulmonary 186 (54.4) 165 (52.1) 0.5
Abdominal 84 (24.6) 108 (34.1) 0.007
Genitourinary 21 (6.1) 26 (8.2) 0.3
Soft tissue 47 (13.7) 24 (7.6) 0.01
Emergency admission 370 (99.5) 334 (94.4) <0.001
Operative admission 89 (23.9) 114 (32.2) 0.01
SAPS without age and renal components 27.0 [21.0–36.0] 26.0 [19.0–34.0] 0.02
SOFA D1 9.0 [7.0–11.0] 9.0 [7.0–11.0] 0.08
APACHE II diagnostic group
Respiratory tract, nonoperative 92 (24.7) 82 (23.2) 0.6
Nonoperative sepsis 72 (19.4) 64 (18.1) 0.7
Gastrointestinal tract, operative 56 (15.1) 71 (20.1) 0.08
Gastrointestinal tract, nonoperative 32 (8.6) 30 (8.5) 0.9
Cardiovascular, nonoperative 30 (8.1) 31 (8.8) 0.7
Neurological, nonoperative 16 (4.3) 7 (2.0) 0.07
Metabolic 16 (4.3) 7 (2.0) 0.07
Trauma 12 (3.2) 5 (1.4) 0.1
Neurological, operative 11 (3.0) 2 (0.6) 0.02
Cardiovascular, operative 5 (1.3) 21 (5.9) 0.001
Treatment restrictions
Any treatment restriction2 100 (26.9) 104 (29.4) 0.5
Withholding of RRT 28 (7.5) 16 (4.5) 0.09
Outcomes
Length of stay ICU (days) 4.1 [2.1–8.1] 4.7 [2.7–8.3] 0.09
Length of stay hospital (days) 15.0 [8.0–25.0] 14.0 [7.0–24.0] 0.2
90-day mortality 126 (33.9) 128 (36.2) 0.5
Probability of death3 0.33 [0.17–0.62] 0.37 [0.17–0.64] 0.4
SMR (95% CI) 0.72 (0.6–0.84) 0.66 (0.58–0.74)
Propensity for RRT4 0.06 [0.03–0.15] 0.06 [0.03–0.24] 0.01
Values are expressed as count (%) and median [interquartile range], except for SMR (with 95% confidence interval). 1Including COPD, chronic cardiovascular
disease, diabetes, thromboembolic disease, chronic liver disease, vasculitis, organ transplant, cancer; 2including withholding and withdrawing of intensive care,
withholding and withdrawal of RRT, and do not resuscitate restrictions; 3calculated from SAPS II score; 4confounders entered to the propensity score: creatinine
value on the first day in the ICU (D1), urine output on the D1, age, any comorbidity, SAPS II score without age and renal components and SOFA score without
renal points on the D1. SOFA D1, Sequential Organ Failure Assessment on the first day in the ICU; APACHE II, Acute Physiology and Chronic Health Evaluation;
SAPS II, Simplified Acute Physiology Score II; AKI, acute kidney injury; KDIGO, Kidney Disease: Improving Global Outcomes; SMR, standardized mortality ratio.
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ICU groups (data not shown). For RRT-treated patients
treatment restrictions were made in 57/131 (43.5%) cases
compared to 147/595 (24.7%) in patients without RRT,
P <0.001.90-day mortality
The crude 90-day mortality rates of patients with septic
shock did not differ between the high-RRT and low-RRT
ICUs (Table 1). Likewise, there was no significant dif-
ference in the crude 90-day mortality in RRT-treated
Table 2 Comparison of organ failures and organ-supportive treatments between high- and low-renal replacement
therapy (RRT) intensive care units (ICUs)
Low RRT-ICUs (n = 372) High RRT-ICUs (n = 354) P value
Septic shock on ICU admission 109 (29.3) 138 (39.0) 0.006
Any AKI 196 (52.7) 240 (67.8) <0.001
KDIGO stage 1 85 (22.8) 82 (23.2) 0.9
KDIGO stage 2 41 (11.0) 43 (12.1) 0.6
KDIGO stage 3 70 (18.8) 115 (32.5) <0.001
KDIGO 3 stage without RRT 37 (9.9) 17 (4.8) 0.008
Cardiovascular failure on D1 317 (85.2) 336 (94.9) <0.001
Respiratory failure on D1 193 (51.9) 179 (50.6) 0.7
Renal failure on D1 53 (14.2) 81 (22.9) 0.003
Liver failure on D1 4 (1.1) 8 (2.3) 0.2
Coagulation failure on D1 24 (6.5) 33 (9.3) 0.2
Central nervous system failure on D1 89 (23.9) 62 (17.5) 0.03
Number of organ failures during ICU stay 2.0 [2.0–3.0] 2.0 [2.0–3.0] 0.8
0–1 organ failure 81 (21.8) 84 (23.7) 0.5
2 organ failures 149 (40.1) 138 (39.0) 0.8
3–4 organ failures 139 (37.4) 112 (31.6) 0.1
5–6 organ failures 3 (0.8) 20 (5.6) <0.001
Supportive treatments
Mechanical ventilation 276 (74.2) 297 (83.9) <0.001
Sepsis corticosteroid 99 (27.0) 138 (40.0) <0.001
RRT 33 (8.9) 98 (27.7) <0.001
Maximum dose of norepinephrine during the first five days in the
ICU (μg/kg/min)
0.18 [0.08–0.38] 0.25 [0.13–0.67] <0.001
Received furosemide 262 (70.4) 285 (80.5) 0.002
Values are expressed as count (%) and median [interquartile range]. AKI, acute kidney injury; KDIGO, Kidney Disease: Improving Global Outcomes; D1, first day in
the ICU.
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95% CI 38.8 to 59.1%), and low-RRT ICUs (57.6%,
95% CI 40.4 to 74.5%), P = 0.39 (Figure 1). The probability
of death and SMRs of patients with septic shock or those
treated with RRT between the ICU groups did not differ
(Table 1 and Additional file 2). Of the 71 patients with re-
stricted RRT (withhold or withdrawal), 60 (84.5%) died
within 90 days. In an adjusted multivariate logistic regres-
sion model the group of ICU (high- or low-RRT ICUs)
and use of RRT were not associated with 90-day mortality
and the result remained after adjustment with propensity
score of RRT (Table 4).
Discussion
In this prospective multicenter study we found a 10-fold
variation (3% to 36%) in the proportion of RRT among
patients with septic shock across Finnish ICUs. There
were significant differences in case-mix and severity of
organ dysfunctions between the high- and low-RRT ICUs,
but indications for and modality of RRT were comparable.Despite the variation in proportion of RRT the 90-day
mortality rates for patients with septic shock or RRT-
treated patients with septic shock did not differ between
the ICU groups.
Absolute and proportional RRT volume in patients with
septic shock
In the present study 18% of patients with septic shock
received RRT. Our finding is in concordance with a re-
cent French study [6] but other studies have reported
much higher proportions of RRT use in this group of pa-
tients varying from 30% up to 71% [3,7,21].
The differences in case-mix between low and high-
RRT ICUs explained the variation in the proportion of
RRT-treated patients. Although SAPS II score and SOFA
score did not differ between ICU groups, patients in the
high-RRT ICUs were more severely ill in terms of pre-
sences of septic shock on ICU admission, number of pa-
tients with renal failure (SOFA 3 to 4) within the first
day in the ICUs, and number of patients with at least
Table 3 Treatment indication, modality, and anticoagulation of renal replacement therapy (RRT) in the low-RRT and
high-RRT intensive care units (ICUs)
Low-RRT ICUs (n = 33) High-RRT ICUs (n = 98) P value
Indication of RRT
Oliguria 29 (87.9) 83 (84.7) 0.7
High creatinine 25 (75.8) 54 (55.1) 0.04
Acidosis 24 (72.7) 72 (73.5) 0.9
Hyperkalemia 9 (27.3) 20 (20.4) 0.4
Fluid overload 12 (36.4) 43 (43.9) 0.4
Intoxication 2 (6.1) 3 (3.0) 0.4
Modality of RRT
Only CRRT during ICU 20 (60.6) 52 (53.1) 0.5
Only IRRT during ICU 2 (6.1) 11 (11.2) 0.4
Both CRRT + IRRT during ICU 11 (33.3) 35 (35.7) 0.8
Time to initiation of RRT from ICU admission (hours) 17.8 [5.2–33.7] 13.5 [5.2–33.2] 0.9
Received anticoagulation 32 (97) 83 (84.7) 0.06
Citrate 23 (69.7) 40 (40.8) 0.004
LMWH 18 (54.5) 65 (66.3) 0.2
Other 0 7 (7.1) 0.1
None 4 (12.1) 27 (27.6) 0.07
Complications related to RRT
Complication in insertion of catheter 8 (24.2) 10 (10.2) 0.04
Electrolyte disturbances 7 (21.2) 19 (19.4) 0.8
Hypotension during RRT 1 (3.0) 2 (2.0) 0.7
Bleeding 2 (6.1) 1 (1.0) 0.09
Catheter-related infection 0 1 (1.0) 0.6
Values are expressed as count (%) and median [interquartile range]. CRRT, continuous renal replacement therapy; IRRT, intermittent renal replacement therapy;
LMWH, low-molecular-weight heparin.
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RRT in septic shock, these patients also received other
organ-supportive treatments more often, such as mech-
anical ventilation, sepsis corticosteroid treatment, and
higher maximum doses of norepinephrine during the
first five days in the ICU in the high-RRT ICUs. Likewise
the number of patients at risk for RRT (patients with
AKI KDIGO stage 1 to 3) was significantly higher in the
high-RRT ICU group.
Indications, modality, and complications of RRT
The national guideline for the treatment of AKI was
published in Finland in 2009 [22], which may explain
the high rate of corresponding indications for and mo-
dalities of RRT between high-RRT and low-RRT ICUs in
the treatment of patients with septic shock. In addition,
the main indications for RRT in both ICU groups were
in concordance with the B.E.S.T. study [9]. Likewise, the
frequencies of complications of RRT, except for catheter
insertion complications, did not differ between high-RRT
and low-RRT ICUs.Treatment restrictions and 90-day mortality
In the present study treatment restrictions were made in
a quarter of patients with septic shock without RRT
compared to nearly 45% of RRT-treated patients. The
high-RRT and the low-RRT ICUs did not differ in fre-
quency of restriction of RRT and there were no differences
in age, number of comorbidities or severity of illness in
patients with restricted initiation of RRT between ICU
groups. Severity of illness, poor prognosis, and age has
been shown to associate with treatment restrictions in pa-
tients with AKI [23]. In our study, however, the with-
drawal from RRT treatment was more frequent in the
low-RRT ICUs. Likewise, AKI has been reported to be as-
sociated with a higher rate of withdrawal of intensive care
treatment than with other supportive treatments [24]. In a
study of hypothetical patient cases physicians were more
likely to withhold or withdraw dialysis or mechanical ven-
tilation than other treatments [25].
The 90-day mortality rates did not differ between ICU
groups regardless of the substantial variation in the
proportion of RRT-treated patients with septic shock.
Table 4 Results of univariable and multivariable logistic regression analyses for factors associated with 90-day
mortality in patients with septic shock
Univariable analyses Multivariable analyses Propensity score4 adjusted
multivariable analyses
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Age Not included
45–54 years1 1.54 (0.7–3.37) 0.28 1.76 (0.73–4.28) 0.21
55–64 years1 1.9 (0.94–3.82) 0.08 2.09 (0.95–4.6) 0.07
65–74 years1 4.06 (2.06–8.02) <0.001 5.52 (2.57–11.89) <0.001
≥75 years1 5.62 (2.86–11.04) <0.001 8.26 (3.83–17.81) <0.001
Operative admission 0.57 (0.4–0.81) 0.002 0.63 (0.42–0.96) 0.03 0.6 (0.4–0.89) 0.01
SAPS II without age and renal points 1.05 (1.04–1.07) <0.001 1.05 (1.03–1.07) <0.001 Not included
Renal failure within the first day on the ICUs 3.17 (2.16–4.66) <0.001 1.91 (1.1–3.31) 0.02 Not included
Mechanical ventilation 1.91 (1.27–2.87) 0.002 1.26 (0.76–2.09) 0.38 1.77 (1.12–2.77) 0.01
Highest norepinephrine dose (μg/kg/min)2 2.74 (1.92–3.91) <0.001 1.02 (1.01–1.03) <0.001 1.02 (1.01–1.02) <0.001
Lowest BE value3 0.94 (0.92–0.96) <0.001 0.98 (0.95–1.01) 0.11 0.97 (0.94–1.0) 0.05
High RRT ICU group 1.11 (0.82–1.5) 0.52 0.89 (0.59–1.34) 0.57 0.88 (0.6–1.29) 0.50
RRT*RRT group (interaction term) 1.97 (1.28–3.02) 0.02 0.67 (0.24–1.85) 0.43 0.7 (0.27–1.79) 0.45
1Compared to patients under 44 years of age; 2the highest norepinephrine dose during the first five days in the ICU; 3the lowest BE value 24 hours prior to ICU
admission or within the first 24 hours in the ICU; 4confounders entered to the propensity score: creatinine value on the first day in the ICU (D1), urine output on
the D1, age groups according to APACHE II score, any comorbidity, SAPS II score without age and renal components and SOFA score without renal points on the
D1. OR odds ratio; CI, confidence interval; SAPS II, Simplified Acute Physiology Score II; RRT, renal replacement therapy; ICU, intensive care unit.
Multivariable model without the propensity score: Hosmer-Lemeshow P = 0.59 and −2 log likelihood = 738.8. Multivariable model with the propensity score:
Hosmer-Lemeshow P = 0.46 and −2 log likelihood =800.2.
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group of ICU (low- or high-RRT ICUs) was also not asso-
ciated with mortality. This result was supported by the
equal SMR values between low- and high-RRT ICUs. Ta-
ken together, our finding suggests that resource utilization
during the study period was equal with corresponding pa-
tient selection for RRT treatment. In contrast to other re-
cent studies [10,11,26], the use of RRT was not associated
with 90-day mortality in the present study.
Limitations
The strengths of our study are the prospective data col-
lection and multicenter study design covering the majo-
rity of the adult population in Finland [12]. Our study
does, however, have some limitations. First, the relatively
small number of RRT-treated patients with septic shock
in both ICU groups makes it difficult to draw robust
conclusions whether these patients or indications for
RRT were similar in the low- and high-RRT ICUs. Also
the study period (five months) may have influenced the
proportion of RRT-treated patients in each ICU due to
seasonal alterations in the number of septic shock pa-
tients needing RRT treatment. We believe, however, that
our finding reflects the genuine practice of RRT in sep-
tic shock across Finnish ICUs. Second, our definition of
high- and low-RRT ICUs may be considered arbitrary.
The relatively small number of patients with septic shock
with only a few RRT-treated patients would give a highproportion of RRT. Also the units we classified as high-
RRT ICUs may be considered as low elsewhere according
to the absolute number of cases. However, instead of
evaluating the impact of the size of ICU, we attempted to
assess the association of administration of RRT treatment
with the 90-day mortality in patients with septic shock.
Third, the most severely ill patients (for example severe
trauma and patients requiring neurosurgery or cardiac
surgery) were transferred to university ICUs for special
treatment. This may have decreased the proportion of
RRT-treated patients in the transferring ICU. University
and central hospital ICUs were, however, equally repre-
sented in the high- and low-RRT ICUs. Fourth, we evalu-
ated only patients treated in the ICU. Finally, since no
global guidelines on the initiation of or indication for RRT
exist, treatment selection bias may have influenced our re-
sults. Although we generated the propensity score for
RRT to decrease the treatment selection bias, some sig-
nificant confounders may be missing from the analysis.
Likewise as our study was an observational study, we can-
not determine whether the indication for RRT or absence
of RRT was relevant. This may also under- or overestimate
the proportion of RRT-treated patients in each ICU.
Conclusions
Patients with septic shock in ICUs with a high propor-
tion of RRT had more severe organ dysfunctions and
received more organ-supportive treatments. The ICU
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with 90-day mortality.
Key messages
 Differences in case mix and severity of organ
dysfunctions in patients with septic shock across
Finnish ICUs explained the 10-fold variation in the
proportion of RRT-treated patients.
 The indications for and modality of RRT were
mainly corresponding between high- and low-RRT
ICUs.
 The crude 90-day mortality rates as well as the
standardized mortality ratios did not differ between
high-RRT and low-RRT ICUs.
 In adjusted logistic regression analysis the ICU
group (high- or low-RRT group) was not associated
with 90-day mortality.
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